▶ 調査レポート

世界の着床前遺伝子スクリーニング(PGS)技術市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Preimplantation Genetic Screening (PGS) Technology Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の着床前遺伝子スクリーニング(PGS)技術市場規模・現状・予測(2021年-2027年) / Global Preimplantation Genetic Screening (PGS) Technology Market Size, Status and Forecast 2021-2027 / QFJ1-4753資料のイメージです。• レポートコード:QFJ1-4753
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、着床前遺伝子スクリーニング(PGS)技術の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(次世代シーケンシング、ポリメラーゼ連鎖反応、蛍光in situハイブリダイゼーション、比較ゲノムハイブリダイゼーション、一塩基多型)、用途別市場規模(マタニティセンター&不妊治療クリニック、病院、研究所・学術機関、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・着床前遺伝子スクリーニング(PGS)技術の市場動向
・企業の競争状況、市場シェア
・着床前遺伝子スクリーニング(PGS)技術の種類別市場規模と予測2016-2027(次世代シーケンシング、ポリメラーゼ連鎖反応、蛍光in situハイブリダイゼーション、比較ゲノムハイブリダイゼーション、一塩基多型)
・着床前遺伝子スクリーニング(PGS)技術の用途別市場規模と予測2016-2027(マタニティセンター&不妊治療クリニック、病院、研究所・学術機関、その他)
・着床前遺伝子スクリーニング(PGS)技術の北米市場規模2016-2027(アメリカ、カナダ)
・着床前遺伝子スクリーニング(PGS)技術の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・着床前遺伝子スクリーニング(PGS)技術のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・着床前遺伝子スクリーニング(PGS)技術の中南米市場規模2016-2027(メキシコ、ブラジル)
・着床前遺伝子スクリーニング(PGS)技術の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Illumina、Thermo Fisher Scientific、Agilent Technologies、PerkinElmer、Coopersurgical、Natera、Takara Bio、Oxford Gene Technology、INVICTA、Genea、Progenesis、Igenomix、Reproductive Health and Wellness Center)
・結論

Preimplantation genetic screening (PGS) determines the chromosomal status of an embryo by screening all 23 chromosome pairs prior to transfer in an IVF cycle.

Market Analysis and Insights: Global Preimplantation Genetic Screening (PGS) Technology Market
The global Preimplantation Genetic Screening (PGS) Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preimplantation Genetic Screening (PGS) Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preimplantation Genetic Screening (PGS) Technology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preimplantation Genetic Screening (PGS) Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preimplantation Genetic Screening (PGS) Technology market.

Global Preimplantation Genetic Screening (PGS) Technology Scope and Market Size
Preimplantation Genetic Screening (PGS) Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetic Screening (PGS) Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism

Segment by Application
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Next-generation Sequencing
1.2.3 Polymerase Chain Reaction
1.2.4 Fluorescence in Situ Hybridization
1.2.5 Comparative Genomic Hybridization
1.2.6 Single-nucleotide Polymorphism
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Screening (PGS) Technology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals
1.3.4 Research Laboratories & Academic Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Perspective (2016-2027)
2.2 Preimplantation Genetic Screening (PGS) Technology Growth Trends by Regions
2.2.1 Preimplantation Genetic Screening (PGS) Technology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preimplantation Genetic Screening (PGS) Technology Historic Market Share by Regions (2016-2021)
2.2.3 Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Regions (2022-2027)
2.3 Preimplantation Genetic Screening (PGS) Technology Industry Dynamic
2.3.1 Preimplantation Genetic Screening (PGS) Technology Market Trends
2.3.2 Preimplantation Genetic Screening (PGS) Technology Market Drivers
2.3.3 Preimplantation Genetic Screening (PGS) Technology Market Challenges
2.3.4 Preimplantation Genetic Screening (PGS) Technology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue
3.1.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue (2016-2021)
3.1.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Players (2016-2021)
3.2 Global Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Screening (PGS) Technology Revenue
3.4 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Screening (PGS) Technology Revenue in 2020
3.5 Preimplantation Genetic Screening (PGS) Technology Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Screening (PGS) Technology Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Screening (PGS) Technology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Type
4.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Type (2016-2021)
4.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2022-2027)

5 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Application
5.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Application (2016-2021)
5.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size (2016-2027)
6.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type
6.2.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021)
6.2.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027)
6.2.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2027)
6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application
6.3.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021)
6.3.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027)
6.3.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2027)
6.4 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country
6.4.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021)
6.4.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size (2016-2027)
7.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type
7.2.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021)
7.2.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027)
7.2.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2027)
7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application
7.3.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021)
7.3.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027)
7.3.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2027)
7.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country
7.4.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021)
7.4.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size (2016-2027)
8.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type
8.2.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2027)
8.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application
8.3.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2027)
8.4 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region
8.4.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size (2016-2027)
9.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type
9.2.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021)
9.2.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027)
9.2.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2027)
9.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application
9.3.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021)
9.3.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027)
9.3.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2027)
9.4 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country
9.4.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021)
9.4.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size (2016-2027)
10.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type
10.2.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2027)
10.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application
10.3.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2027)
10.4 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country
10.4.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Introduction
11.1.4 Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Introduction
11.2.4 Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Introduction
11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Introduction
11.4.4 PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.4.5 PerkinElmer Recent Development
11.5 Coopersurgical
11.5.1 Coopersurgical Company Details
11.5.2 Coopersurgical Business Overview
11.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Introduction
11.5.4 Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.5.5 Coopersurgical Recent Development
11.6 Natera
11.6.1 Natera Company Details
11.6.2 Natera Business Overview
11.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Introduction
11.6.4 Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.6.5 Natera Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Introduction
11.7.4 Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.7.5 Takara Bio Recent Development
11.8 Oxford Gene Technology
11.8.1 Oxford Gene Technology Company Details
11.8.2 Oxford Gene Technology Business Overview
11.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Introduction
11.8.4 Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.8.5 Oxford Gene Technology Recent Development
11.9 INVICTA
11.9.1 INVICTA Company Details
11.9.2 INVICTA Business Overview
11.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Introduction
11.9.4 INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.9.5 INVICTA Recent Development
11.10 Genea
11.10.1 Genea Company Details
11.10.2 Genea Business Overview
11.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Introduction
11.10.4 Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.10.5 Genea Recent Development
11.11 Progenesis
11.11.1 Progenesis Company Details
11.11.2 Progenesis Business Overview
11.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Introduction
11.11.4 Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.11.5 Progenesis Recent Development
11.12 Igenomix
11.12.1 Igenomix Company Details
11.12.2 Igenomix Business Overview
11.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Introduction
11.12.4 Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.12.5 Igenomix Recent Development
11.13 Reproductive Health and Wellness Center
11.13.1 Reproductive Health and Wellness Center Company Details
11.13.2 Reproductive Health and Wellness Center Business Overview
11.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Introduction
11.13.4 Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
11.13.5 Reproductive Health and Wellness Center Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Next-generation Sequencing
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Fluorescence in Situ Hybridization
Table 5. Key Players of Comparative Genomic Hybridization
Table 6. Key Players of Single-nucleotide Polymorphism
Table 7. Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Regions (2016-2021)
Table 11. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Regions (2022-2027)
Table 13. Preimplantation Genetic Screening (PGS) Technology Market Trends
Table 14. Preimplantation Genetic Screening (PGS) Technology Market Drivers
Table 15. Preimplantation Genetic Screening (PGS) Technology Market Challenges
Table 16. Preimplantation Genetic Screening (PGS) Technology Market Restraints
Table 17. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Players (2016-2021)
Table 19. Global Top Preimplantation Genetic Screening (PGS) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Screening (PGS) Technology as of 2020)
Table 20. Ranking of Global Top Preimplantation Genetic Screening (PGS) Technology Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Preimplantation Genetic Screening (PGS) Technology Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Preimplantation Genetic Screening (PGS) Technology Product Solution and Service
Table 24. Date of Enter into Preimplantation Genetic Screening (PGS) Technology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2016-2021)
Table 28. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Preimplantation Genetic Screening (PGS) Technology Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2016-2021)
Table 32. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 64. Illumina Company Details
Table 65. Illumina Business Overview
Table 66. Illumina Preimplantation Genetic Screening (PGS) Technology Product
Table 67. Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 68. Illumina Recent Development
Table 69. Thermo Fisher Scientific Company Details
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product
Table 72. Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Agilent Technologies Company Details
Table 75. Agilent Technologies Business Overview
Table 76. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product
Table 77. Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 78. Agilent Technologies Recent Development
Table 79. PerkinElmer Company Details
Table 80. PerkinElmer Business Overview
Table 81. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product
Table 82. PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 83. PerkinElmer Recent Development
Table 84. Coopersurgical Company Details
Table 85. Coopersurgical Business Overview
Table 86. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product
Table 87. Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 88. Coopersurgical Recent Development
Table 89. Natera Company Details
Table 90. Natera Business Overview
Table 91. Natera Preimplantation Genetic Screening (PGS) Technology Product
Table 92. Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 93. Natera Recent Development
Table 94. Takara Bio Company Details
Table 95. Takara Bio Business Overview
Table 96. Takara Bio Preimplantation Genetic Screening (PGS) Technology Product
Table 97. Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 98. Takara Bio Recent Development
Table 99. Oxford Gene Technology Company Details
Table 100. Oxford Gene Technology Business Overview
Table 101. Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 102. Oxford Gene Technology Recent Development
Table 103. INVICTA Company Details
Table 104. INVICTA Business Overview
Table 105. INVICTA Preimplantation Genetic Screening (PGS) Technology Product
Table 106. INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 107. INVICTA Recent Development
Table 108. Genea Company Details
Table 109. Genea Business Overview
Table 110. Genea Preimplantation Genetic Screening (PGS) Technology Product
Table 111. Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 112. Genea Recent Development
Table 113. Progenesis Company Details
Table 114. Progenesis Business Overview
Table 115. Progenesis Preimplantation Genetic Screening (PGS) Technology Product
Table 116. Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 117. Progenesis Recent Development
Table 118. Igenomix Company Details
Table 119. Igenomix Business Overview
Table 120. Igenomix Preimplantation Genetic Screening (PGS) Technology Product
Table 121. Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 122. Igenomix Recent Development
Table 123. Reproductive Health and Wellness Center Company Details
Table 124. Reproductive Health and Wellness Center Business Overview
Table 125. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product
Table 126. Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021) & (US$ Million)
Table 127. Reproductive Health and Wellness Center Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Type: 2020 VS 2027
Figure 2. Next-generation Sequencing Features
Figure 3. Polymerase Chain Reaction Features
Figure 4. Fluorescence in Situ Hybridization Features
Figure 5. Comparative Genomic Hybridization Features
Figure 6. Single-nucleotide Polymorphism Features
Figure 7. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Application: 2020 VS 2027
Figure 8. Maternity Centers & Fertility Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Research Laboratories & Academic Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Preimplantation Genetic Screening (PGS) Technology Report Years Considered
Figure 13. Global Preimplantation Genetic Screening (PGS) Technology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Preimplantation Genetic Screening (PGS) Technology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Regions: 2020 VS 2027
Figure 16. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Regions (2022-2027)
Figure 17. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Players in 2020
Figure 18. Global Top Preimplantation Genetic Screening (PGS) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Screening (PGS) Technology as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Preimplantation Genetic Screening (PGS) Technology Revenue in 2020
Figure 20. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2016-2021)
Figure 21. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2022-2027)
Figure 22. North America Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2016-2027)
Figure 24. North America Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2016-2027)
Figure 25. North America Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2016-2027)
Figure 26. United States Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2016-2027)
Figure 30. Europe Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2016-2027)
Figure 31. Europe Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2016-2027)
Figure 32. Germany Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Share by Region (2016-2027)
Figure 42. China Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2016-2027)
Figure 50. Latin America Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2016-2027)
Figure 51. Latin America Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2016-2027)
Figure 52. Mexico Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2016-2027)
Figure 58. Turkey Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Illumina Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 63. Agilent Technologies Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 64. PerkinElmer Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 65. Coopersurgical Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 66. Natera Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 67. Takara Bio Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 68. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 69. INVICTA Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 70. Genea Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 71. Progenesis Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 72. Igenomix Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 73. Reproductive Health and Wellness Center Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed